Coagulation System Activation for Targeting of COVID-19: Insights into Anticoagulants, Vaccine-Loaded Nanoparticles, and Hypercoagulability in COVID-19 Vaccines

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also known as COVID-19, is currently developing into a rapidly disseminating and an overwhelming worldwide pandemic. In severe COVID-19 cases, hypercoagulability and inflammation are two crucial complications responsible for poor prog...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdel-Bakky, Mohamed S., Amin, Elham, Ewees, Mohamed G., Mahmoud, Nesreen I., Mohammed, Hamdoon A., Altowayan, Waleed M., Abdellatif, Ahmed A. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876839/
https://www.ncbi.nlm.nih.gov/pubmed/35215822
http://dx.doi.org/10.3390/v14020228

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876839/
https://www.ncbi.nlm.nih.gov/pubmed/35215822
http://dx.doi.org/10.3390/v14020228

Ejemplares similares